Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VELCADE + Rituximab in Relapsed/Refractory Indolent B-Cell Lymphoma
NCT00085696Phase 2Completed
- Sponsor
- Millennium Pharmaceuticals
- Start
- May 2004
- Primary completion
- Apr 2006
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in follicular lymphoma (FL), marginal zone lymphoma (MZL), sponsored by Millennium Pharmaceuticals. Started May 2004; status: completed.
02
Drugs
bortezomib
03
Conditions
follicular lymphoma (FL)marginal zone lymphoma (MZL)
Beyond the preview
Go deeper on NCT00085696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00085696.